392 related articles for article (PubMed ID: 4405144)
41. [Use of leukocyte group typing in human organ transplantation].
Botha MC
Bibl Haematol; 1971; 37():39-52. PubMed ID: 4945043
[No Abstract] [Full Text] [Related]
42. Passive enhancement of renal allografts. Specificity of the enhancing antisera.
Fabre JW; Batchelor JR
Transplantation; 1975 Sep; 20(3):269-71. PubMed ID: 1099733
[No Abstract] [Full Text] [Related]
43. [Importance of the immunological enhancement for the survival time of a homologous graft].
Benkö A
Z Gesamte Inn Med; 1971 Jun; 26(11):345-52. PubMed ID: 4397958
[No Abstract] [Full Text] [Related]
44. Phenotypic expression of the main histocompatibility complex (DL-A) in randomly selected mongrel dogs. 3. Inhibition of the mixed leukocyte culture reaction during and after sensitization to skin allografts.
Bachvaroff R; Ozaki A; Cannon FD; Mollen N; Blumenstock DA; Ayvazian JH; Ferrebee JW; Rapaport FT
Transplant Proc; 1973 Dec; 5(4):1863-8. PubMed ID: 4272835
[No Abstract] [Full Text] [Related]
45. Mechanisms of immunological enhancement.
Cruse JM; Lewis GK; Whitten HD; Watson ES; Fields JF; Adams ST; Harvey GF; Paslay JW; Porter M
Prog Exp Tumor Res; 1974; 19():110-56. PubMed ID: 4140539
[No Abstract] [Full Text] [Related]
46. Prevention of allograft rejection by induction of specific transplantation tolerance with immunomanipulation using total lymphoid irradiation.
Slavin S; Gottlieb M; Bieber C; Hoppe RT; Fuks Z; Grumet FC; Kaplan HS; Strober S
Adv Nephrol Necker Hosp; 1980; 9():209-19. PubMed ID: 6447439
[No Abstract] [Full Text] [Related]
47. Lymphocyte-antibody interactions in immunological enhancement.
Takasugi M; Hildemann WH
Transplant Proc; 1969 Mar; 1(1):530-4. PubMed ID: 5406837
[No Abstract] [Full Text] [Related]
48. The protective effect of F(ab') 2 and succinylated IgG in the early treatment of hyperacute rejection in the primate.
Habal MB; Carpenter CB; Kobayashi K; Bush GJ; Misra M; Birtch AG
Transplant Proc; 1973 Mar; 5(1):601-6. PubMed ID: 4633093
[No Abstract] [Full Text] [Related]
49. Role of organ-specific antigens in the AgB-compatible graft rejection.
Sakai A; Kashiwabara H; Taha M; Kountz SL
Transplant Proc; 1977 Mar; 9(1):629-32. PubMed ID: 68595
[No Abstract] [Full Text] [Related]
50. Control of homograft (allograft) rejection.
Holman HR
Adv Intern Med; 1970; 16():265-83. PubMed ID: 4393810
[No Abstract] [Full Text] [Related]
51. Passive enhancement of canine renal allografts with polyspecific F(ab')2 fragments.
Wren SF; Martins AC; Von Haefen U; Busch GJ; Katske GE; Koppenheffer TL; Shaipanich T; Wilson RE
Surgery; 1974 Jul; 76(1):112-20. PubMed ID: 4135410
[No Abstract] [Full Text] [Related]
52. Renal transplantation in rabbits. IX. An immunological study of the allograft reaction in rabbits pre-sensitized by donor kidney homogenate.
Hansen ES; Lund B; Ahrons S
Acta Pathol Microbiol Scand A; 1972; 80(6):827-34. PubMed ID: 4144026
[No Abstract] [Full Text] [Related]
53. Mechanism of long term survival of renal allografts after treatment with antilymphocyte antibody.
Guttmann RD; Lindquist RR; Ockner SA; Merrill JP
Transplant Proc; 1969 Mar; 1(1):463-6. PubMed ID: 4944260
[No Abstract] [Full Text] [Related]
54. Cytotoxic antibody after antigen pretreatment: enhancement of renal allografts.
Holl-Allen RT; Scharli A; Rippin A; Busch GJ; Simonian SJ; Wilson RE
Surg Forum; 1969; 20():276-8. PubMed ID: 4910594
[No Abstract] [Full Text] [Related]
55. The weaker the histoincompatibility, the greater the effectiveness of specific immunoblocking antibodies: a new immunogenetic rule of transplantation.
Hildemann WH; Mullen Y
Transplant Proc; 1973 Mar; 5(1):617-20. PubMed ID: 4572121
[No Abstract] [Full Text] [Related]
56. Preliminary results with passive enhancement in human kidney transplantation.
Solheim BG; Flatmark A; Thorsby E
Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):53-8. PubMed ID: 781818
[TBL] [Abstract][Full Text] [Related]
57. Antibody turnover by enhanced rat kidneys.
French ME
Transplant Proc; 1973 Mar; 5(1):621-3. PubMed ID: 4572122
[No Abstract] [Full Text] [Related]
58. The distribution of antibody and antibody-producing cells after immunization with xenogeneic cells.
Harding B; MacLennan IC
Immunology; 1972 Jul; 23(1):35-43. PubMed ID: 4558093
[TBL] [Abstract][Full Text] [Related]
59. Developing ways of reducing allograft immunogenicity.
Guttmann RD
Can Med Assoc J; 1981 Jan; 124(2):143-5. PubMed ID: 7006782
[No Abstract] [Full Text] [Related]
60. The absence of early rejection crises in human renal allografts as predicted by capillary agglutinating antibodies.
Stiller CR; Olson R; Haystead J; Dossetor JB
Transplantation; 1972 Oct; 14(4):521-3. PubMed ID: 4566168
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
